Cargando…

Second Primary Neoplasms in Thyroid Cancer Patients

To determine risk patterns for second primary neoplasms after the occurrence of thyroid cancer, we conducted a retrospective cohort study of 3321 thyroid cancer patients who were operated and histologically confirmed at the Noguchi Thyroid Clinic and Hospital Foundation between 1946 and 1985. They w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Kazuhiro, Noguchi, Shiro, Tanaka, Keitaro, Fukuda, Atsushi, Hirohata, Tomio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921095/
https://www.ncbi.nlm.nih.gov/pubmed/8613424
http://dx.doi.org/10.1111/j.1349-7006.1996.tb00211.x
_version_ 1783317937244864512
author Ishikawa, Kazuhiro
Noguchi, Shiro
Tanaka, Keitaro
Fukuda, Atsushi
Hirohata, Tomio
author_facet Ishikawa, Kazuhiro
Noguchi, Shiro
Tanaka, Keitaro
Fukuda, Atsushi
Hirohata, Tomio
author_sort Ishikawa, Kazuhiro
collection PubMed
description To determine risk patterns for second primary neoplasms after the occurrence of thyroid cancer, we conducted a retrospective cohort study of 3321 thyroid cancer patients who were operated and histologically confirmed at the Noguchi Thyroid Clinic and Hospital Foundation between 1946 and 1985. They were followed from the date of operation through the end of 1990 with an observation period from 45 to 5 years. The average observation period of the patients was 13.4 years and the follow‐up rate reached 98%. The standardized mortality ratio (SMR) was computed to assess possible risk increase by cancer site. In this computation, the time period less than 5 years after operation was omitted to reduce the influence of deaths related to the original thyroid cancer. A total of 103 deaths from malignant neoplasms other than thyroid cancer were observed during this time period (SMR=1.6, 95% confidence interval [CI]=1.3–2.0). Analyses of site‐specific cancer mortality revealed significantly elevated risks for the central nervous system (SMR=16.1, CI=5,2–37.6) and respiratory organs (SMR=2.6, CI=1.5–4.1). Based on a review of available medical records with histological findings, we concluded that the risk increases for these sites were most likely to be attributable to second primary neoplasms. Whether or not the patients had received radiotherapy was not significantly associated with elevated risk. Further investigations are needed to clarify the risk factors responsible for the above findings.
format Online
Article
Text
id pubmed-5921095
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59210952018-05-11 Second Primary Neoplasms in Thyroid Cancer Patients Ishikawa, Kazuhiro Noguchi, Shiro Tanaka, Keitaro Fukuda, Atsushi Hirohata, Tomio Jpn J Cancer Res Article To determine risk patterns for second primary neoplasms after the occurrence of thyroid cancer, we conducted a retrospective cohort study of 3321 thyroid cancer patients who were operated and histologically confirmed at the Noguchi Thyroid Clinic and Hospital Foundation between 1946 and 1985. They were followed from the date of operation through the end of 1990 with an observation period from 45 to 5 years. The average observation period of the patients was 13.4 years and the follow‐up rate reached 98%. The standardized mortality ratio (SMR) was computed to assess possible risk increase by cancer site. In this computation, the time period less than 5 years after operation was omitted to reduce the influence of deaths related to the original thyroid cancer. A total of 103 deaths from malignant neoplasms other than thyroid cancer were observed during this time period (SMR=1.6, 95% confidence interval [CI]=1.3–2.0). Analyses of site‐specific cancer mortality revealed significantly elevated risks for the central nervous system (SMR=16.1, CI=5,2–37.6) and respiratory organs (SMR=2.6, CI=1.5–4.1). Based on a review of available medical records with histological findings, we concluded that the risk increases for these sites were most likely to be attributable to second primary neoplasms. Whether or not the patients had received radiotherapy was not significantly associated with elevated risk. Further investigations are needed to clarify the risk factors responsible for the above findings. Blackwell Publishing Ltd 1996-03 /pmc/articles/PMC5921095/ /pubmed/8613424 http://dx.doi.org/10.1111/j.1349-7006.1996.tb00211.x Text en
spellingShingle Article
Ishikawa, Kazuhiro
Noguchi, Shiro
Tanaka, Keitaro
Fukuda, Atsushi
Hirohata, Tomio
Second Primary Neoplasms in Thyroid Cancer Patients
title Second Primary Neoplasms in Thyroid Cancer Patients
title_full Second Primary Neoplasms in Thyroid Cancer Patients
title_fullStr Second Primary Neoplasms in Thyroid Cancer Patients
title_full_unstemmed Second Primary Neoplasms in Thyroid Cancer Patients
title_short Second Primary Neoplasms in Thyroid Cancer Patients
title_sort second primary neoplasms in thyroid cancer patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921095/
https://www.ncbi.nlm.nih.gov/pubmed/8613424
http://dx.doi.org/10.1111/j.1349-7006.1996.tb00211.x
work_keys_str_mv AT ishikawakazuhiro secondprimaryneoplasmsinthyroidcancerpatients
AT noguchishiro secondprimaryneoplasmsinthyroidcancerpatients
AT tanakakeitaro secondprimaryneoplasmsinthyroidcancerpatients
AT fukudaatsushi secondprimaryneoplasmsinthyroidcancerpatients
AT hirohatatomio secondprimaryneoplasmsinthyroidcancerpatients